CHEMED CORP (CHE) earnings date, results and what the price requires
NYSE · SEC CIK 0000019584 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 28, 2026 | $673.3M | $67.7M | $5.13 | Filing |
| Mar 31, 2026 | Apr 23, 2026 | $657.5M | $66.3M | $4.84 | Filing |
| Dec 31, 2025 | Feb 25, 2026 | $639.3M | $-188.2M | $5.45 | Filing |
| Sep 30, 2025 | Oct 28, 2025 | $624.9M | $64.2M | $4.46 | Filing |
| Jun 30, 2025 | Jul 29, 2025 | $618.8M | $52.5M | $3.57 | Filing |
| Mar 31, 2025 | Apr 23, 2025 | $646.9M | $71.8M | $4.86 | Filing |
| Dec 31, 2024 | Feb 26, 2025 | $411.0M | $-211.4M | $6.00 | Filing |
| Sep 30, 2024 | Oct 29, 2024 | $391.4M | $75.8M | $5.00 | Filing |
What would CHEMED CORP have to report for its valuation to change?
At $515.44, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 17.3% a year, to $44.06. On that path the next quarter needs diluted EPS near $5.23, against $4.46 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 17.3% | 17.3% |
| EPS needed in final year | $44.06 | $44.06 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. CHE goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.